October 10th announcement of the weaker than expected full-year revenue numbers drove Accuride Corp. (NYSE: ACW) share price down in 2 weeks to below $2.60/share. Market analysts were already forecasting ACW’s loss of 30 cents per share on revenue of $967.8 million instead of previous Accuride’s prediction of full-year loss at 5 cents to 12 […]
Gevo Inc. (GEVO) Gevo Inc. may be among a set of biofuel producers competing for supply contracts from the U.S. Defense Department. In case of winning one of the small initial grants GEVO will be on the list for large, long-term fuel-supply contracts. Gevo Inc. 345 Inverness Drive South, Building C, Suite 310 Englewood, CO 80112 Tel: […]
Mattson Technology, Inc. (MTSN) announced on October 11th that the company will host a conference call on Wednesday, October 24, 2012 at 5:00 p.m. Eastern Time. The conference call will cover 2012 third quarter financial results and current business conditions. Technology: The Helios® features an advanced model based temperature measurement and control system that provides […]
Shelron Group , Inc. (SRNG) today announced that Dr. Alexandre Agaian, President and Chairman of Terra Energy and Resource Technologies, Inc. (“Terra”), has agreed to join the advisory board of The Shelron Group. Dr. Agaian’s bio: Dr. Agaian is a published scientific researcher, serial entrepreneur, and accomplished company builder. Since 2003, he has concentrated his […]
Majesco Entertainment Co. (COOL) Majesco Entertainment Co. stock plunged since mid-October after the video-game publisher reported fiscal third-quarter earnings that fell well short of Wall Street forecast and a steep drop in revenues. As of today the technical indicators suggest potential bounce of the COOL’s stock. Majesco Entertainment Company 160 Raritan Center Parkway, Edison, NJ […]
Bio-AMD, Inc. (BIAD) shares gain 16% on Friday’s trading session within 9fold 10day average volume. With a tiny market capitalization below $4M and two products ready for the commercialization, BIAD deserves to be added to your watch list. Keep in mind that the Company’s current focus is on securing commercial agreements with major distributors and […]
by BiotechIll Guest Author Cell Therapeutics, Inc. (CTIC) today announced that its paclitaxel poliglumex drug OPAXIO has been granted orphan-drug designation by the U. S Food and Drug Administration for the treatment of malignant brain cancer (glioblastoma multiforme). CTIC stock closed up 11.2% on the 4fold of its 10day average volume. Phase 2 study has […]
by MisterQ Guest Author Dehaier Medical Systems Ltd. (DHRM) stock gained over 15% on Friday’s trading session within almost a million shares in volume after company’s announcement of a two-year exclusive distribution agreement with GCE group for GCE’s EASE II products in Mainland China. EASE II device is an automatically triggered high-flow oxygen device, which […]
by MisterQ Guest Author LodgeNet Interactive Corporation (LNET) stock today traded 1/7th of its float despite of the public announcement that Mr. Mark Cuban, #188 in Forbes List for United States, owner of Dallas Mavericks & beneficial owner of more than 6% of the LodgeNet (lol), sold on open market ~700K LNET shares since the […]
Peregrine Pharmaceuticals (PPHM ) announced today that it discovered major discrepancies between some patient sample test results and patient treatment code assignments during the course of preparing for an end-of-phase II meeting with regulatory authorities. Peregrine contracted with independent third-party contractors to execute treatment group assignments and oversee clinical trial material coding and distribution according […]
